FWBI

First Wave BioPharma (FWBI)

First Wave BioPharma Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:FWBI

1 2 3 4 5 6 7 8 9 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/06/24	21:03	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:FWBI	First Wave BioPharma Inc
2024/06/21	05:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FWBI	First Wave BioPharma Inc
2024/06/18	06:23	Edgar (US Regulatory)	Form PRER14A - Preliminary Proxy Soliciting materials	NASDAQ:FWBI	First Wave BioPharma Inc
2024/06/15	06:15	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:FWBI	First Wave BioPharma Inc
2024/06/11	13:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:FWBI	First Wave BioPharma Inc
2024/06/06	06:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FWBI	First Wave BioPharma Inc
2024/06/01	06:25	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:FWBI	First Wave BioPharma Inc
2024/05/31	06:32	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:FWBI	First Wave BioPharma Inc
2024/05/31	06:18	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NASDAQ:FWBI	First Wave BioPharma Inc
2024/05/16	20:16	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FWBI	First Wave BioPharma Inc
2024/05/16	20:00	GlobeNewswire Inc.	First Wave BioPharma Changes Name to Entero Therapeutics	NASDAQ:FWBI	First Wave BioPharma Inc
2024/05/15	06:26	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:FWBI	First Wave BioPharma Inc
2024/05/14	06:26	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FWBI	First Wave BioPharma Inc
2024/05/14	05:59	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:FWBI	First Wave BioPharma Inc
2024/05/10	20:55	GlobeNewswire Inc.	First Wave BioPharma, Inc. to raise approximately $1.1 million of Gross Proceeds Priced At-the-Market	NASDAQ:FWBI	First Wave BioPharma Inc
2024/05/09	20:00	GlobeNewswire Inc.	First Wave BioPharma and Celiac Journey to Host Nasdaq Event in Support of Celiac Disease Awareness Month	NASDAQ:FWBI	First Wave BioPharma Inc
2024/05/09	06:16	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NASDAQ:FWBI	First Wave BioPharma Inc
2024/04/24	20:00	GlobeNewswire Inc.	First Wave BioPharma Announces Invited Paper for Special Edition on Celiac Disease in Peer-Reviewed Scientific Journal, Nutrients	NASDAQ:FWBI	First Wave BioPharma Inc
2024/04/17	20:00	GlobeNewswire Inc.	First Wave BioPharma CEO James Sapirstein to Present at the Planet MicroCap Showcase	NASDAQ:FWBI	First Wave BioPharma Inc
2024/04/15	20:00	GlobeNewswire Inc.	First Wave BioPharma CEO James Sapirstein to Participate in 2024 Longwood Healthcare Leaders Conference	NASDAQ:FWBI	First Wave BioPharma Inc
2024/03/18	20:00	GlobeNewswire Inc.	First Wave BioPharma Announces Two Abstracts on Celiac Disease Research Accepted for Presentation at the 2024 Digestive Disease Week (DDW) Conference	NASDAQ:FWBI	First Wave BioPharma Inc
2024/03/14	19:00	GlobeNewswire Inc.	First Wave BioPharma Announces Completion of Business Combination with ImmunogenX, Adding Phase 3-Ready Latiglutenase to its Late-Stage GI-Focused Clinical Pipeline	NASDAQ:FWBI	First Wave BioPharma Inc
2024/03/06	07:26	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FWBI	First Wave BioPharma Inc
2024/03/05	21:00	GlobeNewswire Inc.	First Wave BioPharma to Participate In ‘Fireside Chat’ at the 36th Annual Roth Conference	NASDAQ:FWBI	First Wave BioPharma Inc
2024/03/05	07:29	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:FWBI	First Wave BioPharma Inc
2024/03/04	22:00	GlobeNewswire Inc.	First Wave BioPharma, Inc. to Raise Approximately $4.0 Million of Gross Proceeds in Registered Direct Offering	NASDAQ:FWBI	First Wave BioPharma Inc
2024/02/13	21:00	GlobeNewswire Inc.	First Wave BioPharma CEO to Present at the BIO CEO & Investor Conference 2024	NASDAQ:FWBI	First Wave BioPharma Inc
2024/01/23	21:00	GlobeNewswire Inc.	First Wave BioPharma to Present at the DealFlow MicroCap Conference	NASDAQ:FWBI	First Wave BioPharma Inc
2024/01/19	06:01	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:FWBI	First Wave BioPharma Inc
2024/01/18	14:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:FWBI	First Wave BioPharma Inc